Vaxxel SAS
-
Vaxxel buys Transgene’s DuckCelt-T17 cell line to develop industrial-scale vaccines against respiratory viruses
51 0Vaxxel SAS, a French start-up, developing vaccines against respiratory viral…
Read more
Vaxxel SAS, a French start-up, developing vaccines against respiratory viral…
Read moreMedia error: Format(s) not supported or source(s) not found
Download File: https://pharmaleaders.tv/wp-content/uploads/2015/02/Padma_Shri_Dr_Shashank_Joshi_addressing_at_Pharmaleaders_2014_Summit.mp4?_=1Download File: https://pharmaleaders.tv/wp-content/uploads/2015/02/Padma_Shri_Dr_Shashank_Joshi_addressing_at_Pharmaleaders_2014_Summit.mp4?_=1